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Moore et al have recently published an editorial on ‘Harnessing the power of intelligent 
machines to enhance primary care’.1 Whilst we appreciate the main messages of the 
editorial, we would like to correct the impression given by the authors in relation to one 
of our studies QRISK3.2  As stated in our QRISK3 paper,2 we included seven additional 
parameters in QRISK3 in response to the 2014 update to the NICE guidelines and 
published literature.3-8 These were chronic kidney disease (stages 3, 4, 5); a measure 
of systolic blood pressure variability; migraine; corticosteroids; SLE; atypical 
antipsychotics; severe mental illness. 
 
The paper by Weng et al highlighted only identified two of these,9 and was published the 
year after our paper was submitted to the BMJ.10 It’s inaccurate therefore to attribute 
the development of QRISK3 to machine learning techniques. Also for clarification the 
improvement in accuracy of 3.6% referred to from the paper by Weng et al was not in 
comparison to QRISK2 but to the published equations in the 2013 American ACC/AHA 
guidelines. Their highest c statistic value of 0.764 from the machine-learning algorithms 
was lower than ours for either the current version of QRISK2 (0.879 in women and 0.858 
in men) or the new QRISK3 (0.880 in women and 0.858 in men). 
 
References: 
1. Moore SF, Hamilton W, Llewellyn DJ. Harnessing the power of intelligent machines to 
enhance primary care. Br J Gen Pract 2018;68(666):6-7. doi: 
10.3399/bjgp17X693965. 
2. Hippisley-Cox J, Coupland C, Brindle P. Development and validation of QRISK3 risk 
prediction algorithms to estimate future risk of cardiovascular disease: prospective 
cohort study. BMJ 2017;357 doi: 10.1136/bmj.j2099. 
3. National Clinical Guideline Centre. Lipid modification: cardiovascular risk assessment 
and the modification of blood lipids for the primary and secondary prevention of 
cardiovascular disease. London, 2014:286. 
4. Thompson IM, Tangen CM, Goodman PJ, et al. Erectile dysfunction and subsequent 
cardiovascular disease. JAMA 2005;294(23):2996-3002. doi: 
10.1001/jama.294.23.2996. 
5. Vlachopoulos CV, Terentes-Printzios DG, Ioakeimidis NK, et al. Prediction of 
Cardiovascular Events and All-Cause Mortality With Erectile Dysfunction: A 
Systematic Review and Meta-Analysis of Cohort Studies. Circ Cardiovasc Qual 
Outcomes 2013;6(1):99-109. doi: 10.1161/circoutcomes.112.966903. 
6. Shamloul R, Ghanem H. Erectile dysfunction. Lancet; 381(9861):153-65. doi: 
10.1016/S0140-6736(12)60520-0. 
7. Kurth T, Winter AC, Eliassen AH, et al. Migraine and risk of cardiovascular disease in 
women: prospective cohort study. BMJ 2016;353 doi: 10.1136/bmj.i2610. 
8. Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit 
variability, maximum systolic blood pressure, and episodic 
hypertension. Lancet 2010; 375(9718):895-905. doi: 10.1016/S0140-
6736(10)60308-X. 
9. Weng SF, Reps J, Kai J, et al. Can machine-learning improve cardiovascular risk 
prediction using routine clinical data? PLOS ONE 2017;12(4):e0174944. doi: 
10.1371/journal.pone.0174944. 
10. QRISK3 Peer review. http://www.bmj.com/content/357/bmj.j2099/peer-review BMJ 
2016. 
 
Competing Interests:  
JHC is professor of clinical epidemiology at the University of Nottingham and co-director 
of QResearch® – a not-for-profit organisation which is a joint partnership between the 
University of Nottingham and Egton Medical Information Systems (leading commercial 
supplier of IT for 55% of general practices in the UK). JHC is also a paid director of 
ClinRisk Ltd which produces open and closed source software to ensure the reliable and 
updatable implementation of clinical risk algorithms within clinical computer systems to 
help improve patient care. CC is associate professor of Medical Statistics at the 
University of Nottingham and a paid consultant statistician for ClinRisk Ltd. This work 
and any views expressed within it are solely those of the co-authors and not of any 
affiliated bodies or organisations. 
